Mandate

Vinge advises Active Biotech on rights offering

February 15, 2018 Capital Markets and Public M&A

Active Biotech AB (publ) issues new shares with pre-emptive rights for the shareholders.

The Vinge team includes Erik Sjöman, Christian Lindhé, Astrid Karlsson and Jack Bengtsson.
 

Related

Vinge advises Consolid Equity and other sellers on the sale of Sertion to Altor

Vinge has advised Consolid Equity and other sellers on the sale of the Sertion Group to Altor Fund IV (“Altor”). In connection with the transaction, entrepreneurs and management will reinvest and remain as key owners, partnering with Altor to accelerate the group’s next phase of growth across existing markets and into new geographies.
May 11, 2026

Vinge advises Stendörren in connection with issuance of green capital securities

Vinge has advised Stendörren Fastigheter AB in connection with its issuance of green capital securities in an amount of SEK 400 million (within a framework of SEK 800 million).
May 07, 2026

Vinge advises Ingrid Capacity on its issuance of senior secured bonds in an amount of SEK 400 million

Vinge has acted as legal counsel to Ingrid Capacity AB (publ) in connection with its issuance of senior secured bonds in an aggregate principal amount of SEK 400 million, issued under a total framework amount of SEK 1 billion.
May 07, 2026